Home / Atomoxetine / Austria
AT ATC N06BA09 · updated 2 Nov 2026
Atomoxetine shortage in Austria
Is there an Atomoxetine shortage in Austria?
Yes. As of 2 Nov 2026, 2 Atomoxetine products are reported short in Austria, the first since 9 Apr 2026. The company estimate for the return is 18 Dec 2026. Main reason: quality problem or recall.
Also short in Canada, Germany, Spain, Ireland, Belgium, Czechia, Norway, Sweden, Japan, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Atofab 10 mg-Hartkapseln, 30 Stück | G.L. Pharma GmbH | 9 Apr 2026 | 18 Dec 2026 | Quality problem or recall Rückruf von Chargen am Markt |
| AT | Atofab 10 mg-Hartkapseln, 10 Stück | G.L. Pharma GmbH | 27 May 2026 | 18 Dec 2026 | Quality problem or recall Rückruf von Chargen am Markt |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).